FDA grants Natera MCED assay Breakthrough Device designation
Natera said its multi-cancer early detection (MCED) assay received Breakthrough Device Designation from the U.S. FDA.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results.
FDA grants Breakthrough Device designation to Natera MCED assay
Natera said the U.S. FDA granted Breakthrough Device designation to its multi-cancer early detection (MCED) assay.